S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

AstraZeneca (AZN) News Today

$68.36
-0.17 (-0.25%)
(As of 04/18/2024 ET)
SourceHeadline
marketbeat.com logoQ2 2025 Earnings Forecast for AstraZeneca PLC (NASDAQ:AZN) Issued By Zacks Research
marketbeat.com - April 18 at 6:31 AM
MarketBeat logoAstraZeneca (AZN) to Release Earnings on Thursday
americanbankingnews.com - April 18 at 1:08 AM
benzinga.com logoAmgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
benzinga.com - April 17 at 3:12 PM
MarketBeat logoAstraZeneca (NASDAQ:AZN) Upgraded to Hold at Deutsche Bank Aktiengesellschaft
americanbankingnews.com - April 17 at 4:10 AM
marketbeat.com logoAstraZeneca (NASDAQ:AZN) Upgraded at Deutsche Bank Aktiengesellschaft
marketbeat.com - April 16 at 1:28 PM
benzinga.com logoAstraZeneca's Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows
benzinga.com - April 16 at 9:42 AM
businesswire.com logoAsher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
businesswire.com - April 16 at 8:00 AM
marketbeat.com logoCerity Partners LLC Raises Holdings in AstraZeneca PLC (NASDAQ:AZN)
marketbeat.com - April 16 at 5:52 AM
investorplace.com logo3 Pharma Stocks That Are Money-Printing Machines in 2024
investorplace.com - April 15 at 5:51 PM
marketbeat.com logoFlputnam Investment Management Co. Has $18.33 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)
marketbeat.com - April 15 at 5:35 PM
marketbeat.com logoInternational Assets Investment Management LLC Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)
marketbeat.com - April 14 at 4:42 AM
marketbeat.com logoWCM Investment Management LLC Cuts Holdings in AstraZeneca PLC (NASDAQ:AZN)
marketbeat.com - April 13 at 1:54 PM
MarketBeat logoAstraZeneca (NASDAQ:AZN) Shares Gap Up to $68.11
americanbankingnews.com - April 13 at 5:42 AM
marketbeat.com logoAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Hardman Johnston Global Advisors LLC
marketbeat.com - April 12 at 9:29 PM
marketbeat.com logoAstraZeneca PLC (NASDAQ:AZN) Sees Significant Decline in Short Interest
marketbeat.com - April 12 at 9:16 AM
MarketBeat logoTraders Buy High Volume of AstraZeneca Put Options (NASDAQ:AZN)
americanbankingnews.com - April 12 at 3:48 AM
marketbeat.com logoAstraZeneca Sees Unusually Large Options Volume (NASDAQ:AZN)
marketbeat.com - April 11 at 2:49 PM
uk.investing.com logoFTSE 100 Live: Stocks slip as AstraZeneca pay vote nears; market targets September rate cut
uk.investing.com - April 11 at 9:50 AM
msn.com logoSpotlight on FTSE 100 stock AstraZeneca
msn.com - April 11 at 9:50 AM
benzinga.com logoAstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boost
benzinga.com - April 11 at 9:50 AM
businesswire.com logoFASENRA approved for treatment of children aged 6 to 11 with severe asthma
businesswire.com - April 11 at 7:00 AM
msn.com logoAstraZeneca promises dividend rise ahead of vote on chief’s £18.7m pay deal
msn.com - April 11 at 4:50 AM
msn.com logoAstraZeneca unveils dividend hike ahead of CEO pay vote at AGM
msn.com - April 11 at 4:50 AM
reuters.com logoAstraZeneca unveils dividend hike ahead of CEO pay vote at AGM
reuters.com - April 11 at 2:30 AM
markets.businessinsider.com logoAstraZeneca’s Enhertu Approval Spurs Buy Rating Amid Revenue Growth Projections
markets.businessinsider.com - April 10 at 7:27 AM
MarketBeat logoFY2026 EPS Estimates for AstraZeneca PLC (NASDAQ:AZN) Lifted by Analyst
americanbankingnews.com - April 10 at 2:34 AM
finance.yahoo.com logoZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?
finance.yahoo.com - April 10 at 1:21 AM
barrons.com logoMeet Europe's Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.
barrons.com - April 9 at 11:42 AM
marketbeat.com logoResearch Analysts Issue Forecasts for AstraZeneca PLC's FY2026 Earnings (NASDAQ:AZN)
marketbeat.com - April 9 at 6:25 AM
marketbeat.com logoFirst Merchants Corp Makes New $3.89 Million Investment in AstraZeneca PLC (NASDAQ:AZN)
marketbeat.com - April 7 at 4:21 PM
finance.yahoo.com logoIncreases to CEO Compensation Might Be Put On Hold For Now at AstraZeneca PLC (LON:AZN)
finance.yahoo.com - April 6 at 7:23 AM
businesswire.com logoENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
businesswire.com - April 5 at 11:10 PM
markets.businessinsider.com logoFDA Approves AstraZeneca And Daiichi Sankyo's Enhertu For Solid Tumors Treatment
markets.businessinsider.com - April 5 at 10:46 PM
businesswire.com logoENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first tumor-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumors
businesswire.com - April 5 at 9:43 PM
reuters.com logoUS FDA approves Daiichi, AstraZeneca drug for treatment of solid tumors
reuters.com - April 5 at 5:45 PM
msn.com logoNew Hope for Aggressive Lung Cancer: AstraZeneca's Imfinzi Shows Promising Results in Phase 3 Trial
msn.com - April 5 at 12:44 PM
msn.com logoAstraZeneca Imfinzi improves survival in late-stage lung cancer trial
msn.com - April 5 at 8:44 AM
reuters.com logoAstraZeneca's Imfinzi shows promise in treating aggressive lung cancer
reuters.com - April 5 at 2:43 AM
marketbeat.com logoAstraZeneca PLC (NASDAQ:AZN) Shares Acquired by China Universal Asset Management Co. Ltd.
marketbeat.com - April 4 at 6:45 PM
marketbeat.com logoAstraZeneca (NASDAQ:AZN) Shares Gap Up to $66.81
marketbeat.com - April 4 at 1:21 PM
marketbeat.com logoZacks Research Weighs in on AstraZeneca PLC's Q1 2025 Earnings (NASDAQ:AZN)
marketbeat.com - April 4 at 9:29 AM
cnbc.com logoHealthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
cnbc.com - April 3 at 1:33 PM
marketbeat.com logoMiracle Mile Advisors LLC Cuts Stock Position in AstraZeneca PLC (NASDAQ:AZN)
marketbeat.com - April 3 at 5:27 AM
marketbeat.com logoTIAA Trust National Association Sells 29,621 Shares of AstraZeneca PLC (NASDAQ:AZN)
marketbeat.com - April 2 at 5:09 PM
benzinga.com logoAstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
benzinga.com - April 2 at 3:26 PM
msn.com logoFDA accepts Daiichi Sankyo-AstraZeneca's breast cancer therapy for review
msn.com - April 2 at 8:36 AM
businesswire.com logoDatopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
businesswire.com - April 2 at 2:00 AM
msn.com logoAstraZeneca gets FDA approval for PNH drug Voydeya
msn.com - April 1 at 3:34 PM
finance.yahoo.com logoAstraZeneca gets FDA OK for rare disease drug acquired in Alexion buyout
finance.yahoo.com - April 1 at 8:56 AM
marketbeat.com logoChicago Capital LLC Buys New Holdings in AstraZeneca PLC (NASDAQ:AZN)
marketbeat.com - April 1 at 8:48 AM
Get AstraZeneca News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.

AI “wealth window” is closing soon! (Ad)

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

Biotech Boom: Stocks Skyrocketing & What's Next

AZN Media Mentions By Week

AZN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AZN
News Sentiment

0.70

0.50

Average
Medical
News Sentiment

AZN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AZN Articles
This Week

18

14

AZN Articles
Average Week

Get AstraZeneca News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AZN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners